From:
`Sent:
`To:
`
`Cc:
`Subject:
`
`Wong, Jovial <JWong@winston.com>
`Monday, February 20, 2017 3:04 PM
`Donovan, Bindu; Olson, Isaac; Monsen, Alyssa; Langford, Andrew; Politi, Terry; Pritikin,
`David T.
`Klein, Chuck; Park, Sam; Hauer, Ryan B.; Lin, Sharon; Creasey, David W.; Munoz, Ruben
`RE: BTG Int'l et al. v. Actavis Labs. FL et al. No. 15-cv-5909 (D.N.J.) - Mylan IPR joinder
`
`Bindu,
`
`
`Further to your email below, please let us know by Wednesday February 22 whether Janssen consents to our clients
`joining the Mylan IPR. If so, we will inform the Board of the same. To the extent Janssen intends to oppose our motion
`for joinder or cannot respond by Wednesday, we will request that the Board expedite briefing on the joinder issue and/or
`inform the Board that Janssen did not respond to our repeated inquiries regarding consent.
`
`
`Regards,
`Jovial
`
`Jovial Wong
`Partner
`Winston & Strawn LLP
`1700 K Street, N.W.
`Washington, DC 20006-3817
`D: +1 (202) 282-5867
`F: +1 (202) 282-5100
`Bio | VCard | Email | winston.com
`
`
`
`
`
`From: Donovan, Bindu [mailto:bdonovan@sidley.com]
`Sent: Wednesday, February 08, 2017 6:56 PM
`To: Wong, Jovial <JWong@winston.com>; Olson, Isaac <iolson@sidley.com>; Monsen, Alyssa <amonsen@sidley.com>;
`Langford, Andrew <alangford@sidley.com>; Politi, Terry <tpoliti@sidley.com>; Pritikin, David T. <dpritikin@sidley.com>
`Cc: Klein, Chuck <CKlein@winston.com>; Park, Sam <SPark@winston.com>; Hauer, Ryan B. <RHauer@winston.com>;
`Lin, Sharon <SLin@winston.com>; Creasey, David W. <DCreasey@winston.com>; Munoz, Ruben
`<rmunoz@AKINGUMP.com>
`Subject: RE: BTG Int'l et al. v. Actavis Labs. FL et al. No. 15-cv-5909 (D.N.J.) - Mylan IPR joinder
`
`
`Jovial,
`
`Thank you for your email. We are unable to respond at this time. We will provide our position in our response
`to your clients’ motion for joinder after we have had an opportunity to consider your filings.
`
`Best regards, Bindu
`
`
`BINDU DONOVAN
`Partner
`
`1
`
`JANSSEN EXHIBIT 2012
`Actavis et al. v. Janssen IPR2017-00853
`
`

`

`
`SIDLEY AUSTIN LLP
`+1 212 839 8742
`bdonovan@sidley.com
`
`
`
`From: Wong, Jovial [mailto:JWong@winston.com]
`Sent: Wednesday, February 08, 2017 10:36 AM
`To: Donovan, Bindu; Olson, Isaac; Monsen, Alyssa; Langford, Andrew; Politi, Terry; Pritikin, David T.
`Cc: Klein, Chuck; Park, Sam; Hauer, Ryan B.; Lin, Sharon; Creasey, David W.; Munoz, Ruben
`Subject: RE: BTG Int'l et al. v. Actavis Labs. FL et al. No. 15-cv-5909 (D.N.J.) - Mylan IPR joinder
`
`Bindu,
`
`For clarification, by taking a secondary role in the Mylan IPR proceedings if joined, our clients intend to rely on
`the same prior art and expert testimony submitted by Mylan, will agree to not submit any separate briefing on any
`issue (unless the issue pertains specifically to one of our clients and not to Mylan), and will agree to participate
`only as observers during depositions. That said, our clients reserve the right to take a primary and lead role in the
`IPR proceedings in the case that Mylan reaches a settlement with the patent owner Janssen or otherwise
`withdraws or no longer participates in the proceedings.
`
`Let me know if you have any further questions, or want to discuss any of these clarifications. If not, please let us
`know whether our clients have Janssen’s consent to join the Mylan IPR.
`
`Regards,
`Jovial
`
`Jovial Wong
`Partner
`Winston & Strawn LLP
`1700 K Street, N.W.
`Washington, DC 20006-3817
`D: +1 (202) 282-5867
`F: +1 (202) 282-5100
`Bio | VCard | Email | winston.com
`
`
`
`
`
`From: Donovan, Bindu [mailto:bdonovan@sidley.com]
`Sent: Wednesday, February 08, 2017 8:42 AM
`To: Wong, Jovial <JWong@winston.com>; Olson, Isaac <iolson@sidley.com>; Monsen, Alyssa
`<amonsen@sidley.com>; Langford, Andrew <alangford@sidley.com>; Politi, Terry <tpoliti@sidley.com>; Pritikin,
`David T. <dpritikin@sidley.com>
`Cc: Klein, Chuck <CKlein@winston.com>; Park, Sam <SPark@winston.com>; Hauer, Ryan B.
`<RHauer@winston.com>; Lin, Sharon <SLin@winston.com>; Creasey, David W. <DCreasey@winston.com>;
`Munoz, Ruben <rmunoz@AKINGUMP.com>
`Subject: RE: BTG Int'l et al. v. Actavis Labs. FL et al. No. 15-cv-5909 (D.N.J.) - Mylan IPR joinder
`
`Jovial,
`
`
`2
`
`

`

`Your email does not provide sufficient information for us to determine whether we can consent to
`your clients’ motion to join the Mylan IPR. In particular, your email does not explain what is meant by
`“maintain a secondary role in the proceedings.” For example:
`
`
`- Do your clients intend to rely on the same prior art and expert testimony submitted by Mylan?
`- Do your clients agree that they will not be permitted to submit any separate briefing on any
`issue?
`- Do your clients agree that they will not be permitted to participate in depositions, other than
`as observers?
`
`
`Please explain in detail what you mean by “secondary role.”
`
`Best regards, Bindu
`
`
`BINDU DONOVAN
`Partner
`
`Sidley Austin LLP
`+1 212 839 8742
`bdonovan@sidley.com
`
`
`
`From: Wong, Jovial [mailto:JWong@winston.com]
`Sent: Tuesday, February 07, 2017 2:29 PM
`To: Donovan, Bindu; Olson, Isaac; Monsen, Alyssa; Langford, Andrew; Politi, Terry; Pritikin, David T.
`Cc: Klein, Chuck; Park, Sam; Hauer, Ryan B.; Lin, Sharon; Creasey, David W.
`Subject: RE: BTG Int'l et al. v. Actavis Labs. FL et al. No. 15-cv-5909 (D.N.J.) - Mylan IPR joinder
`
`Bindu,
`
`As discussed with you today, our clients (Actavis, Amneal, DRL, Sun, Teva, and West-Ward) will be
`filing an IPR petition for the ‘438 patent and a motion to join the Mylan IPR (IPR2016-01332). Our
`intent is to rely on the same grounds/set of experts as in the Mylan IPR, not request any alterations to the
`current schedule in the Mylan IPR, and maintain a secondary role in the proceedings.
`
`Please let us know by 2pm ET tomorrow whether Janssen opposes our clients joining the Mylan IPR.
`
`Regards,
`Jovial
`
`Jovial Wong
`Partner
`Winston & Strawn LLP
`1700 K Street, N.W.
`Washington, DC 20006-3817
`D: +1 (202) 282-5867
`F: +1 (202) 282-5100
`Bio | VCard | Email | winston.com
`
`3
`
`
`
`
`
`

`

`The contents of this message may be privileged and confidential. If this message has been received in error, please delete it without reading
`it. Your receipt of this message is not intended to waive any applicable privilege. Please do not disseminate this message without the
`permission of the author. Any tax advice contained in this email was not intended to be used, and cannot be used, by you (or any other
`taxpayer) to avoid penalties under applicable tax laws and regulations.
`
`
`
`
`
`************************************************************************************
`****************
`This e-mail is sent by a law firm and may contain information that is privileged or confidential.
`If you are not the intended recipient, please delete the e-mail and any attachments and notify us
`immediately.
`
`************************************************************************************
`****************
`
`4
`
`